Thermo Fisher Scientific has signed an asset purchase agreement with Nephromics, which includes a patent licence for exclusive rights to use PlGF (Placental Growth Factor) for the diagnosis of pre-eclampsia or eclampsia.
Scientex has recently acquired five new agencies to further bolster the range of products it offers to the scientific community. It has secured exclusive distribution rights for Australia and New Zealand for leading technologies used by scientists across life sciences, industry and research.
Plexpress, developer of the innovative TRAC platform for high-throughput gene expression analysis, has announced a collaboration with the contract research organisation Admescope which will now include TRAC as part of its services for investigating in vitro drug interactions and preclinical ADME-Tox responses.
GE Healthcare has announced that it has completed the acquisition of Xcellerex, a supplier of manufacturing technologies for the biopharmaceutical industry.
Qiagen NV has announced the acquisition of AmniSure International LLC, a privately owned Boston company that markets the AmniSure assay for determining whether a pregnant woman is suffering rupture of foetal membranes (ROM), a condition in which fluid leaks from the amniotic sac prematurely.
UniQuest, The University of Queensland’s (UQ) main commercialisation company, has announced a $4.3 million strategic alliance with Axiom Molecular in radiopharmaceutical research, development and commercialisation.
Sigma-Aldrich has acquired all outstanding shares of Cleveland-based company Research Organics to expand its buffer production capacity and to increase its portfolio of PharmaGrade raw materials for the biopharmaceutical and diagnostic markets.
Contract medical company IQnovate has signed a memorandum of understanding with JH Biotech Australasia to commercialise and extract research and development efficiencies related to a range of biotechnology products, including ones suitable for animal nutrition.
United Bioresearch has been appointed Australian distributor for the full range of ACTGene products.
Sigma-Aldrich has completed its acquisition of BioReliance Holdings from Avista Capital Partners for $350 million in cash, subject to normal post-closing adjustments.
Middletons acted on behalf of the sellers of the Australian and South-East Asian generic pharmaceutical business Ascent Pharmahealth, which was purchased by Watson Pharmaceuticals.
United Bioresearch Products has been appointed as the Australian distributor for the Biomedica range of ELISA kits and antibodies.
Sartorius concludes agreement to acquire the liquid handling business of Finnish laboratory supplier Biohit.
AMS Instrumentation & Calibration has been appointed exclusive distributor for the Michell Instruments range of analytical instrumentation for Australia. The company manufactures dewpoint transmitters, cooled mirror hygrometers, relative humidity sensors, process moisture analysers, hydrocarbon dewpoint analysers, moisture in liquid analysers and oxygen analysers.
Rigaku acquires handheld Raman products from BaySpec.